Old Web
English
Sign In
Acemap
>
Paper
>
Cerebrospinal fluid biomarker outcomes in a trial of docosahexaenoic acid (DHA) for Alzheimer's disease
Cerebrospinal fluid biomarker outcomes in a trial of docosahexaenoic acid (DHA) for Alzheimer's disease
2010
Joseph F. Quinn
Ronald G. Thomas
Rema Raman
Karin Yurko-Mauro
Eileen Bailey-Hall
Edward B. Nelson
Les Shaw
Paul S. Aisen
Keywords:
Psychology
Docosahexaenoic acid
Diabetes mellitus
Disease
Biomarker (medicine)
Cerebrospinal fluid
Internal medicine
Psychiatry
Gastroenterology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]